Sid Sankaran - 09 Apr 2026 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Reporting relationship: Director
Issuer ticker: OSCR
Reported as of: 09 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Apr 2026, 16:16:40 UTC
Prior SEC filing: 06 Jun 2025
Next SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Melissa Curtin, Attorney-in-Fact

Key filing fact

Sid Sankaran filed Form 4 for Oscar Health, Inc. (OSCR) on 13 Apr 2026.

Key facts

This page summarizes Sid Sankaran's Form 4 filing for Oscar Health, Inc. (OSCR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Apr 2026, 16:16.

Change

Previous filing in this sequence was filed on 06 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001509066 Primary reporting owner

Sankaran Sid

Relationship: Director
Address: 75 VARICK STREET, 5TH FLOOR, NEW YORK
Signature: /s/ Melissa Curtin, Attorney-in-Fact
Signature date: 13 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OSCR transaction Derivative

Deferred Stock Unit

Award

Transaction value
Shares: +1,203
Change %
Price: $14.54^*
Shares after: 1,203
Date: 09 Apr 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 1,203
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.

Footnote F2

The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.

Footnote F3

The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on April 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.